Hepion Pharmaceuticals, Inc. (HEPA): EBITDA
-$19.32M
Year ended 2024-12-31
| Period ended | EBITDA | Change YoY | Source filing |
|---|---|---|---|
| 2024-12-31 | -$19.32M | n/m | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | -$48.38M | n/m | 2025-04-08, From 2023-01-01 |
| 2022-12-31 | -$45.41M | n/m | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | -$30.32M | n/m | 2023-04-10, From 2021-01-01 |
| 2020-12-31 | -$20.11M | n/m | 2022-04-08, From 2020-01-01 |
| 2019-12-31 | -$7.74M | n/m | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$14.58M | n/a | 2020-05-14, From 2018-01-01 |
| No annual figure between 2016-06-30 and 2018-12-31. | |||
| 2016-06-30 | -$20.78M | n/m | 2017-09-28, From 2015-07-01 |
| 2015-06-30 | -$13.94M | n/m | 2016-09-28, From 2014-07-01 |
| 2014-06-30 | -$1.67M | n/a | 2015-09-25, From 2013-07-01 |